Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Hydrazide-based HDAC inhibitors and PROTAC degraders in drug discovery: Recent developments and therapeutic applications

Chinese Chemical Letters(2025)10.1016/j.cclet.2025.112263Source: DataRank Database

Hydrazide-based HDAC inhibitors and PROTAC degraders in drug discovery: Recent developments and therapeutic applications is a research paper published in Chinese Chemical Letters (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

0 citations · base score 0

Cite:

datarank_citation_only_1hop_v6· scope data_onlyMethodology

›Data sources & pipeline

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Pending

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

Authors (6)

Yu-Xuan Zhao,Jin-Bo Niu,Jian SongORCID,Sai-Yang ZhangORCID,Yuxuan ZhaoORCID